Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

The objective of the present study was to validate the use of intralesional injection of interleukin-2 (IL-2) in patients with skin and soft-tissue melanoma metastases. A total of 24 patients with AJCC stage III or IV melanoma and single or multiple skin and soft-tissue metastases were included. Int...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Radny, P, Caroli, U M, Bauer, J, Paul, T, Schlegel, C, Eigentler, T K, Weide, B, Schwarz, M, Garbe, C
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2003
Onderwerpen:
Clinical
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394422/
https://ncbi.nlm.nih.gov/pubmed/14583759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601320
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items